ACUTE KIDNEY INJURY AND MACROPHAGES OF THE HEART-KIDNEY AXIS IN PATIENTS WITH FATAL MYOCARDIAL INFARCTION
- Authors: Kercheva M.A.1,2, Ryabov V.V.1,2, Gombozhapova A.E.1,2, Stepanov I.V.2
-
Affiliations:
- ''Siberian State Medical University of the Ministry of Healthcare of Russia
- Research institute of Cardiology of Tomsk National Research Medical Center of the Russian Academy of Sciences National Research Tomsk State University
- Issue: Vol 8, No 9 (2022)
- Pages: 44-52
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/276818
- DOI: https://doi.org/10.18565/therapy.2022.9.44-52
- ID: 276818
Cite item
Abstract
Full Text
About the authors
Maria A. Kercheva
''Siberian State Medical University of the Ministry of Healthcare of Russia; Research institute of Cardiology of Tomsk National Research Medical Center of the Russian Academy of Sciences National Research Tomsk State University
Email: mariiakercheva@mail.ru
PhD in Medicine, junior researcher at the Central Research Laboratory; researcher at the Department of emergency cardiology 634050, Tomsk, 2 build. 18 Moskovsky Tract
Vyacheslav V. Ryabov
''Siberian State Medical University of the Ministry of Healthcare of Russia; Research institute of Cardiology of Tomsk National Research Medical Center of the Russian Academy of Sciences National Research Tomsk State University
Email: rvvt@cardio-tomsk.ru
Dr. med. habil., professor, head of the Department of cardiology; deputy director for scientific and medical work, acting head of the Department of emergency cardiology, leading researcher at the Laboratory of translational cellular and molecular biomedicine 634009. Tomsk, 5 Kooperativny Lane
Alexandra E. Gombozhapova
''Siberian State Medical University of the Ministry of Healthcare of Russia; Research institute of Cardiology of Tomsk National Research Medical Center of the Russian Academy of Sciences National Research Tomsk State University
Email: gombozhapova@gmail.com
PhD in Medicine, researcher, cardiologist at the Department of emergency cardiology; assistant at the Department of cardiology of the Advanced Training Faculty and University Staff Faculty; junior researcher at the Laboratory of translational cellular and molecular biomedicine 634009. Tomsk, 5 Kooperativny Lane
Ivan V. Stepanov
Research institute of Cardiology of Tomsk National Research Medical Center of the Russian Academy of Sciences National Research Tomsk State University
Email: i_v_stepanov@mail.ru
PhD in Medicine, pathologist, head of еру Department ща pathological anatomy 634009. Tomsk, 5 Kooperativny Lane
References
- Wang C., Pei Y.Y., Ma Y.H. et al. Risk factors for acute kidney injury in patients with acute myocardial infarction. Chin Med J (Engl). 2019; 132(14): 1660-65. https://dx.doi.org/10.1097/CM9.0000000000000293.
- Межонов Е. М., Вялкина Ю.А., Шалаев С.В. Прогностическое значение острого кардиоренального синдрома у пациентов с острой кардиальной патологией. Кардиология. 2019; 59(8S): 44-55. https://dx.doi.org/10.18087/cardio.2678. EDN: JIUMER.
- Рябова Т.Р., Рябов В.В., Соколов А.А. с соавт. Динамика структурно-геометрических и функциональных показателей левого желудочка в ранние и поздние сроки инфаркта миокарда. Ультразвуковая и функциональная диагностика. 2001; 3: 54-60. EDN: VWTHHX
- Kofman N., Margolis G., Gal-Oz A. et al. Long-term renal outcomes and mortality following renal injury among myocardial infarction patients treated by primary percutaneous intervention. Coron Artery Dis. 2019; 30(2): 87-92. https://dx.doi.org/10.1097/MCA.0000000000000678.
- Gameiro J., Fonseca J.A., Outerelo C., Lopes J.A. Acute kidney injury: From diagnosis to prevention and treatment strategies. J Clin Med. 2020; 9(6): 1704. https://dx.doi.org/10.3390/jcm9061704.
- Ridker P.M., Devalaraja M., Baeres F.M.M. et al. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): A double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2021; 397(10289): 2060-69. https://dx.doi.org/10.1016/S0140-6736(21)00520-1.
- Cantero-Navarro E., Rayego-Mateos S., Orejudo M. et al. Role of macrophages and related cytokines in kidney disease. Front Med (Lausanne). 2021; 8: 688060. https://dx.doi.org/10.3389/fmed.2021.688060
- Fujiu K., Shibata M., Nakayama Y. et al. A heart-brain-kidney network controls adaptation to cardiac stress through tissue macrophage activation. Nat Med. 2017; 23(5): 61 1-22. https://dx.doi.org/10.1038/nm.4326.
- Sij H., de Boer R. Heart failure: Macrophages take center stage in the heart-brain kidney axis. Nat Rev Nephrol. 2017; 13(7): 388-90. https://dx.doi.org/10.1038/nrneph.2017.73.
- Kercheva M., Ryabov V., Gombozhapova A. et al. Macrophages of the «heart-kidney» axis: Their dynamics and correlations with clinical data and outcomes in patients with myocardial infarction. J Pers Med. 2022; 12(2): 127. https://dx.doi.org/10.3390/jpm12020127.
- Керчева М.А., Рябов В.В. Роль макрофагов в формировании кардиоренального синдрома при инфаркте миокарда. Российский кардиологический журнал. 2021; 26(4): 143-148. https://dx.doi.org/10.15829/1560-4071-2021-4309. EDN: KMBDDD.
- Ryabov V., Gombozhapova A., Rogovskaya Y. et al. Cardiac CD68+ and stabilin-1+ macrophages in wound healing following myocardial infarction: From experiment to clinic. Immunobiology. 2018; 223(4-5): 413-21. https://dx.doi.org/10.1016/j.imbio.2017.11.006.
- Gaut J.P., Liapis H. Acute kidney injury pathology and pathophysiology: a retrospective review. Clin Kidney J. 2021; 14(2): 526-36. https://dx.doi.org/10.1093/ckj/sfaa142.
- Baylis R., Gomez D., Mallat Z. et al. The CANTOS trial: One important step for clinical cardiology but a giant leap for vascular biology. Arterioscler Thromb Vasc Biol. 2017; 37(11): e174-e177. https://dx.doi.org/10.1161/ATVBAHA.117.310097.
- Гомбожапова А.Э., Роговская Ю.В., Ребенкова М.С. с соавт. Фенотипическая гетерогенность сердечных макрофагов в постинфарктной регенерации миокарда: перспективы клинических исследований. Сибирский журнал клинической и экспериментальной медицины. 2018; 33(2): 70-76. https://dx.doi.org/10.29001/2073-8552-2018-33-2-70-76. EDN: XTXQDJ.
- Evans B., Haskard D., Sempowksi G. et al. Evolution of the macrophage CD163 phenotype and cytokine profiles in a human model of resolving inflammation.Int J Inflamm. 2013; 2013: 780502. https://dx.doi.org/10.1155/2013/780502.
- Olmes G., Buttner-Herold M., Ferrazzi F. et al. CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis. Arthritis Res Ther. 2016; 18: 90. https://dx.doi.org/10.1186/s13075-016-0989-y.
- Etzerodt A., Moestrup S. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxidants & Redox Signaling. 2013; 18(17): 2352-63. https://dx.doi.org/10.1089/ars.2012.4834.
- Li J., Liu C., Gao B. et al. Clinical-pathologic significance of CD163 positive macrophage in IgA nephropathy patients with crescents.Int J Clin Exp Med. 2015; 8(6): 9299-305.
- Guillen-Gomez E., Guirado L., Belmonte X. et al. Monocyte implication in renal allograft dysfunction. Clin Exp Immunol. 2014; 175(2): 323-33. https://dx.doi.org/10.1111/cei.12228.
- Guiteras R., Flaquer M., Cruzado J. Macrophage in chronic kidney disease. Clin Kidney J. 2016; 9(6): 765-71. https://dx.doi.org/10.1093/ckj/sfw096
- Chistiakov D., Killingsworth M., Myasoedova V. et al. CD68/macrosialin: Not just a histochemical marker. Lab Invest. 2017; 97(1): 4-13. https://dx.doi.org/10.1038/labinvest.2016.116.
- Marks S., Williams S., Tullus K., Sebire N.J. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis. Nephrol Dial Transplant. 2008; 23(1 1): 3521-26. https://dx.doi.org/10.1093/ndt/gfn270.
- Dias C., Malafronte P., Lee J. et al. Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis. J Nephrol. 2017; 30(1): 87-94. https://dx.doi.org/10.1007/s40620-015-0252-7.
- Kzhyshkowska J. Multifunctional receptor stabilin-1 in homeostasis and disease. Scientific World Journal. 2010; 10: 2039-53. https://dx.doi.org/10.1100/tsw.2010.189.